2m 2m 2m 2m 2m 2m 2m
TARSUS PHARMA (TARS)
NASDAQ
$66.21+$2.65 (+4.17%)
Price as of Jun 23, 2026 5:03 PM EDT- $2.7BMarket Cap
- 56.55%1-Year Change
- BiotechnologyIndustry
TARSUS PHARMA (TARS)
$66.21+$2.65 (+4.17%)
TARS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $63.56 | ||
Change | +$0.40 (+0.63%) | ||
Open | $63.34 | ||
High | $64.21 | ||
Low | $62.51 | ||
Previous Close | $63.16 | ||
Volume | 788,703 | ||
30-Day Average Volume | 645,094 | ||
1-Week Change | 2.76% | ||
1-Month Change | 2.09% | ||
1-Year Change | 56.55% | ||
3-Year Change | 253.31% | ||
5-Year Change | 123.02% | ||
Fundamentals | |||
Shares Outstanding | 43.0M | ||
Total Assets | $581.1M | ||
Market Cap | $2.7B | ||
Enterprise Value | $2.7B | ||
Period: QTR TTM FY | |||
Revenue | $145.4M | ||
Net Income | -$7.0M | ||
Free Cash Flow | -$30.5M | ||
EBIT | -$2.5M | ||
EBITDA | -$2.2M | ||
Net Working Capital | $393.7M | ||
EPS | -$0.16 | ||
Enterprise Value/EBITDA | -1,204 | ||
Enterprise Value/Revenue | 19 | ||
P/B | 8 | ||
P/E | -397 | ||
PEG | -22 | ||
Price/Free Cash Flow | -90 | ||
Price/Operating Cash Flow | -111 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue